Publications by authors named "Hui-Chan He"

Claim this Profile
I
Investigation of the correlation between platelet antibodies and peripheral blood cytopenia in patients with hepatocellular carcinoma.
Rui Han, Hui-Chan He, Wan-Ning Zhang, Ze-Tao Pan, Chen-Yang Feng

Sci Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Zhuo-Yuan Lin, Guo Chen, Yan-Qiong Zhang, Hui-Chan He, Yu-Xiang Liang, Jian-Heng Ye, Yu Zheng

Mol Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Epstein-Barr virus DNA associated with hepatic impairment and its diagnostic and prognostic role in patients with gastric cancer.
Hui-Chan He, Rui Han, Bo-Heng Xu, Chan Huang, Min-Min Li, Cai-Yun He

Front Med (Lausanne)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: A two-stage case-control study.
Yue Li, Hui-Chan He, Da-Lei Zhou, Qing Liu, Xiao Zhang, Cai-Yun He

J Gastroenterol Hepatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer.
Xuan Su, Bo-Heng Xu, Da-Lei Zhou, Zu-Lu Ye, Hui-Chan He, Cai-Yun He

Genomics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers.
Xuan Su, Hui-Chan He, Zu-Lu Ye, Da-Lei Zhou, Qing Liu, Bo-Heng Xu, Wei-Chao Chen, Cai-Yun He

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
Guo Chen, Zhi-Duan Cai, Zhuo-Yuan Lin, Cong Wang, Yu-Xiang Liang, Hui-Chan He

Mol Carcinog· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Zhuo-Yuan Lin, Guo Chen, Yan-Qiong Zhang, Hui-Chan He, Yu-Xiang Liang, Jian-Heng Ye, Yu Zheng

Mol Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.
Ze-Zhen Liu, Zhao-Dong Han, Ying-Ke Liang, Jun-Xu Chen, Song Wan, Hui-Chan He

Cell Signal· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
Ying-Ke Liang, Zhao-Dong Han, Jian-Ming Lu, Ze-Zhen Liu, Yang-Jia Zhuo, Jun-Xu Chen, Jian-Heng Ye, Hui-Chan He

J Cell Biochem· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Yue-Ping Wan, Ming Xi, Hui-Chan He, Song Wan, Wei Hua

Oncol Res Treat· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of GPR30 in estrogen-induced prostate epithelial apoptosis and benign prostatic hyperplasia.
Deng-Liang Yang, Jia-Wen Xu, Jian-Guo Zhu, Yi-Lin Zhang, Jian-Bang Xu, Hui-Chan He

Biochem Biophys Res Commun· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer.
Qing-Biao Chen, Ying-Ke Liang, Yan-Qiong Zhang, Min-Yao Jiang, Zhao-Dong Han, Hui-Chan He

Tumour Biol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Jian-Jiang Xie, Yang-Jia Zhuo, Yu Zheng, Ru-Jun Mo, Ze-Zhen Liu, Hui-Chan He

Int Urol Nephrol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Zhuo-Yuan Lin, Guo Chen, Yan-Qiong Zhang, Hui-Chan He, Yu-Xiang Liang, Jian-Heng Ye, Yu Zheng

Mol Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer.
Yu-Xiang Liang, Jian-Ming Lu, Ru-Jun Mo, Hui-Chan He, Jian Xie, Yan-Ru Chen, Zheng Luo

Int J Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Chao Cai, Qing-Biao Chen, Zhao-Dong Han, Yan-Qiong Zhang, Hui-Chan He, Jia-Hong Chen, Yan-Ru Chen, Sheng-Bang Yang

Clin Cancer Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1.
Jia-Hong Chen, Yu-Xiang Liang, Hui-Chan He, Jin-Yan Chen, Jian-Ming Lu, Guo Chen

Int J Biol Macromol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CC chemokine ligand 18 correlates with malignant progression of prostate cancer.
Guo Chen, Yu-xiang Liang, Jian-guo Zhu, Xin Fu, Yan-fei Chen, Xue-cheng Bi, Hui-chan He, Sheng-bang Yang

Biomed Res Int· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer.
Chao Cai, Jin-Yan Chen, Zhao-Dong Han, Hui-Chan He, Jia-Hong Chen, Yan-Ru Chen, Sheng-Bang Yang

Int J Clin Exp Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer.
Yu-Xiang Liang, Ru-Jun Mo, Hui-Chan He, Jia-Hong Chen, Jun Zou

Oncol Rep· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ten significantly differentially expressed genes in prostate cancer: Screening and verification].
Yong-kang Ye, Qi-wu Mi, Jie-xin Luo, Xiang-jun Meng, Hui-chan He

Zhonghua Nan Ke Xue· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
Hao Fu, Hui-chan He, Zhao-dong Han, Yue-ping Wan, Hong-wei Luo

Tumour Biol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.
Xiao-hui Ling, Zhao-dong Han, Dan Xia, Hui-chan He, Fu-neng Jiang, Jia-hong Chen

Mol Biol Rep· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer.
Guo-Qiang Qin, Hui-Chan He, Zhao-Dong Han, Yu-Xiang Liang, Sheng-Bang Yang

Onco Targets Ther· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis